5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)
Titel:
5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)
Auteur:
Delmer, Alain Tournilhac, Olivier Leprêtre, Stéphane Cazin, Bruno Feugier, Pierre Dreyfus, Brigitte Mahé, Béatrice Leporrier, Michel Michallet, Anne-Sophie Jaccard, Arnaud Divine, Marine Leblond, Véronique Lévy, Vincent Cymbalista, Florence Letestu, Rémi